Skip to content

Evidence of genital shedding of HIV during successful antiretroviral therapy in HIV/HSV-2-coinfected women

More evidence from UK of improvements in prognosis since advent of HAART, but concern over late diagnosis

Triple-class failure emerges slowly in UK patients

Evidence of serosorting after diagnosis with acute HIV infection

HPV vaccine may be of value for women already exposed to some HPV strains

Start treatment when CD4 cell count is 350, say revised US guidelines

English Appeal Court rules that HIV non-disclosure may be 'provocation' (amended)

Starting antiretroviral therapy early at higher CD4 cell counts improves short term treatment outcomes in resource-poor countries

One-third of Rwandan ART patients show lipodystrophy, more common in city dwellers